HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Synergy between the pharmacological chaperone 1-deoxygalactonojirimycin and agalsidase alpha in cultured fibroblasts from patients with Fabry disease.

AuthorsAntonio Pisani, Caterina Porto, Generoso Andria, Giancarlo Parenti
JournalJournal of inherited metabolic disease (J Inherit Metab Dis) Vol. 37 Issue 1 Pg. 145-6 (Jan 2014) ISSN: 1573-2665 [Electronic] United States
PMID23974650 (Publication Type: Letter, Research Support, Non-U.S. Gov't, Comment)
Chemical References
  • Recombinant Proteins
  • 1-Deoxynojirimycin
  • alpha-Galactosidase
Topics
  • 1-Deoxynojirimycin (analogs & derivatives)
  • Fabry Disease (enzymology, metabolism)
  • Fibroblasts (metabolism)
  • Humans
  • Male
  • Recombinant Proteins (metabolism)
  • alpha-Galactosidase (metabolism)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: